Is Darvocet a Narcotic?

Many people taking Darvocet (propoxyphene/acetaminophen) may wonder if the drug is a narcotic. Darvocet is a prescription pain reliever that contains both acetaminophen and a narcotic called propoxyphene. It is generally considered to be a relatively weak painkiller. However, it is classified as a controlled substance and should not be viewed as a "harmless" drug.

Is Darvocet Considered a Narcotic?

Darvocet® (propoxyphene/acetaminophen) is a prescription pain medication. It is a narcotic medication and is classified as a controlled substance.
 

Darvocet and DEA Classification

Controlled substances are drugs (both legal or illegal) that are listed in the Controlled Substances Act. These drugs have the potential to be abused and are subject to specific rules and regulations that are stricter, compared to medications that are not controlled substances.
 
There are different levels or "schedules" of controlled substances, with Schedule I being the most addictive (and with no recognized medicinal purpose) and Schedule V being the least addictive. Darvocet is classified as a Schedule IV drug. This means that it has less abuse potential compared to a Schedule I, II, or III medication but more compared to a Schedule V medication. Examples of other Schedule IV drugs include many sleep medications (such as Ambien®) and anxiety medications (such as Xanax®).
 

Is Darvocet a Strong Narcotic?

Propoxyphene, the narcotic in Darvocet, is actually considered to be a weak narcotic. It is chemically similar to methadone (a very powerful narcotic) but is far less potent. Darvocet is generally considered to be a relatively weak painkiller. However, it should not be viewed as a "harmless" drug. Although it has less abuse potential compared to many other narcotics, Darvocet abuse is a very real and fairly common problem (see Darvocet Addiction for more information).
 
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation